Omadacycline | List of Frontiers open access articles

Original Research

Published on 23 Jul 2025

A matched pilot cohort study of intravenous omadacycline in the treatment of severe pneumonia associated with carbapenem-resistant Acinetobacter baumannii

in Antimicrobials, Resistance and Chemotherapy

Dayu Chen
Yechao Chen
Na Hu
Qiaoling Gu
Jingjing Kan
Jinchun Liu
Haixia Zhang

Frontiers in Microbiology

doi 10.3389/fmicb.2025.1597860

3,142 views

Original Research

Published on 21 Apr 2022

Pharmacokinetics, Safety and Pharmacokinetics/Pharmacodynamics Analysis of Omadacycline in Chinese Healthy Subjects

in Translational Pharmacology

Haijing Yang
Zhiwei Huang
Yuancheng Chen
Yusong Zhu
Guoying Cao
Jingjing Wang
Yan Guo
Jicheng Yu
Jufang Wu
Lichuan Liu

Frontiers in Pharmacology

doi 10.3389/fphar.2022.869237

6,142 views
14 citations

Original Research

Published on 01 Apr 2025

A real-world pharmacovigilance analysis of omadacycline in FDA adverse event reporting system (FAERS) database

in Inflammation Pharmacology

Xueping Shi
Chen Wang
Xiang Liu
Li Zou
Pei Guo

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1558868

4,880 views
5 citations

Original Research

Published on 12 Jun 2024

Omadacycline for the treatment of patients with Legionella pneumophila pneumonia after experiencing liver dysfunction: case series

in Infectious Agents and Disease

Ani Zhu
Qian Ma
Zhiyan Liu

Frontiers in Microbiology

doi 10.3389/fmicb.2024.1408443

2,851 views
2 citations

Clinical Trial

Published on 28 Jul 2023

Omadacycline in the treatment of community-acquired bacterial pneumonia in patients with comorbidities: a post-hoc analysis of the phase 3 OPTIC trial

in Infectious Diseases: Pathogenesis and Therapy

George D. Rodriguez
Nathan Warren
Roman Yashayev
Surya Chitra
Maria Amodio-Groton
Kelly Wright

Frontiers in Medicine

doi 10.3389/fmed.2023.1225710

5,573 views
8 citations

Original Research

Accepted on 06 May 2026

Efficacy of drug regimens containing omadacycline in a murine model of Mycobacterium avium chronic lung infection

in Antimicrobials, Resistance and Chemotherapy

Jessica Pierce
Jean-philippe Lanoix
Alisa W Serio
Antoine Froment
Julia Delomez
Marie Perret
François Peltier
Cédric Joseph
Denis Chatelain
Claire ANDREJAK

Frontiers in Microbiology

143 views

Case Report

Published on 29 Sep 2023

Case Report: Omadacycline in the treatment of macrolide-unresponsive Mycoplasma pneumoniae pneumonia in an adolescent patient

in Antibiotic Resistance and New Antimicrobial drugs

Limin Xu
Changquan Fang

Frontiers in Cellular and Infection Microbiology

doi 10.3389/fcimb.2023.1244398

8,593 views
9 citations

Original Research

Published on 18 Nov 2025

Efficacy and safety of omadacycline for the treatment of infectious diseases: a real-world, retrospective study of 2587 patients

in Pharmacology of Infectious Diseases

Jian Liu
Jiayi Liu
Huangyi Li
Jiali Pang
Siyun Chen
Jianming Liu
Aijun Ouyang

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1706601

2,021 views

Case Report

Published on 21 May 2024

Efficacy of omadacycline in the treatment of Legionella pneumonia: a case report

in Antibiotic Resistance and New Antimicrobial drugs

Yao Wang
Shui-Min Yi
Si-Min Huang
Wei-Xin Xu
Yi-Wen Wei
Qiang Qu
Jian Qu

Frontiers in Cellular and Infection Microbiology

doi 10.3389/fcimb.2024.1380312

3,669 views
5 citations

Original Research

Published on 02 Nov 2020

AdeABC Efflux Pump Controlled by AdeRS Two Component System Conferring Resistance to Tigecycline, Omadacycline and Eravacycline in Clinical Carbapenem Resistant Acinetobacter nosocomialis

in Antimicrobials, Resistance and Chemotherapy

Yi-Tzu Lee
Hsing-Yu Chen
Ya-Sung Yang
Yu-Ching Chou
Tein-Yao Chang
Wei-Jane Hsu
I-Chieh Lin
ACTION Study Group
Jun-Ren Sun

Frontiers in Microbiology

doi 10.3389/fmicb.2020.584789

6,730 views
22 citations

Original Research

Published on 08 Jan 2024

Omadacycline for the treatment of severe pneumonia caused by Chlamydia psittaci complicated with acute respiratory distress syndrome during the COVID-19 pandemic

in Infectious Diseases: Pathogenesis and Therapy

Dao-Xin Wang
Ling-Xi Xiao
Xin-Yu Deng
Wang Deng

Frontiers in Medicine

doi 10.3389/fmed.2023.1207534

6,451 views
12 citations

Original Research

Published on 08 Dec 2021

Omadacycline Potentiates Clarithromycin Activity Against Mycobacterium abscessus

in Experimental Pharmacology and Drug Discovery

Bui Thi Bich Hanh
Nguyen Thanh Quang
Yujin Park
Bo Eun Heo
Seunghyeon Jeon
June-Woo Park
Jichan Jang

Frontiers in Pharmacology

doi 10.3389/fphar.2021.790767

7,601 views
29 citations

Case Report

Published on 12 May 2025

Case Report: Deep sternal wound infection caused by Mycoplasma hominis after cardiac surgery

in Cardiovascular Surgery

Zhaohui Wang
Yong Shi
Yu Chen
Lijun Chen

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2025.1538389

2,089 views
1 citation

Brief Research Report

Published on 10 Mar 2025

Omadacycline successfully treated severe Legionella pneumonia after moxifloxacin treatment failure: Case series

in Pharmacology of Infectious Diseases

Biyun Li
Laiyu Liu
Fei Li
Chunmei He
Yuan Chen
Xiaodong Tian
Zhenyu Liu
Weizhen Zhang

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1559857

3,499 views
3 citations

Case Report

Published on 18 Aug 2025

Omadacycline in the treatment of severe Q fever pneumonia during an influenza epidemic: a case report with literature review

in Infectious Diseases: Pathogenesis and Therapy

Chuanhua Nie
Yuan Zhu
Huajuan Zhou
Xinmin Zhu
Shaohua Hu
Xiaoli Zhao
Xiaohua Zhong
Fengfei Qian
Miao Yu
Qiuting Jiang

Frontiers in Medicine

doi 10.3389/fmed.2025.1626115

2,716 views

Case Report

Published on 19 Aug 2024

Case report: a co-occurring case of severe Mycoplasma pneumoniae pneumonia and Anti-IgLON5 antibody-associated encephalitis in a pediatric patient

in Infectious Diseases: Pathogenesis and Therapy

Zimao Ye
Yuequn Chen
Xin Tian

Frontiers in Medicine

doi 10.3389/fmed.2024.1393540

5,718 views
4 citations

Articles

A matched pilot cohort study of intravenous omadacycline in the treatment of severe pneumonia associated with carbapenem-resistant Acinetobacter baumannii

Pharmacokinetics, Safety and Pharmacokinetics/Pharmacodynamics Analysis of Omadacycline in Chinese Healthy Subjects

A real-world pharmacovigilance analysis of omadacycline in FDA adverse event reporting system (FAERS) database

Omadacycline for the treatment of patients with Legionella pneumophila pneumonia after experiencing liver dysfunction: case series

Omadacycline in the treatment of community-acquired bacterial pneumonia in patients with comorbidities: a post-hoc analysis of the phase 3 OPTIC trial

Efficacy of drug regimens containing omadacycline in a murine model of Mycobacterium avium chronic lung infection

Case Report: Omadacycline in the treatment of macrolide-unresponsive Mycoplasma pneumoniae pneumonia in an adolescent patient

Efficacy and safety of omadacycline for the treatment of infectious diseases: a real-world, retrospective study of 2587 patients

Efficacy of omadacycline in the treatment of Legionella pneumonia: a case report

AdeABC Efflux Pump Controlled by AdeRS Two Component System Conferring Resistance to Tigecycline, Omadacycline and Eravacycline in Clinical Carbapenem Resistant Acinetobacter nosocomialis

Omadacycline for the treatment of severe pneumonia caused by Chlamydia psittaci complicated with acute respiratory distress syndrome during the COVID-19 pandemic

Omadacycline Potentiates Clarithromycin Activity Against Mycobacterium abscessus

Case Report: Deep sternal wound infection caused by Mycoplasma hominis after cardiac surgery

Omadacycline successfully treated severe Legionella pneumonia after moxifloxacin treatment failure: Case series

Omadacycline in the treatment of severe Q fever pneumonia during an influenza epidemic: a case report with literature review

Case report: a co-occurring case of severe Mycoplasma pneumoniae pneumonia and Anti-IgLON5 antibody-associated encephalitis in a pediatric patient